Skip to main content
search

Regulatory

Sign up

Latest resources

Featured resource

Upcoming regulatory webinars

Latest regulatory blogs

Meet our experts at the following events

Conference

ISSX 2025 International Meeting

September 12 - 14, 2025 – Chicago, Illinois
Conference

ACCP Annual Meeting

September 14 - 16, 2025 – Phoenix, Arizona – Booth #4
Conference

BioTechX US 2025

September 16 - 17, 2025 – Philadelphia, PA – Booth #604

All regulatory resources

The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar

Certara Services, Clinical Trials, Drug Development, Webinar

BioTechX US 2025

Certara Products - BaseCase, Certara Products - Simcyp, Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Conference

Accelerate your SDTM Mapping with Pinnacle 21 Enterprise Plus

Certara Products - Pinnacle 21, Data Standards, SDTM, Blog

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Biologics, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation - PK/PD, Publication

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Biologics, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation - PK/PD, Therapeutic Specialties, Publication

Differences between eCTD 4.0 and eCTD 3.2.2 Submissions – What You Need to Know

Certara Products - GlobalSubmit, Webinar

Regulatory Operations Best Practices for Health Canada Submissions

Certara Products - GlobalSubmit, Regulatory, Blog

Replacing Traditional TQT Studies with Model-Based Concentration-QTc (C-QTc) Analysis for Cardiovascular Safety in Drug Development

Cardiovascular, Certara Services, Clinical Pharmacology, Clinical Trials, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation – PK/PD, Blog

De-risking DDI Management during Clinical Trials: Introducing DIDB’s Concomitant Meds Navigator

Certara Products, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Webinar

Model-Based Meta-Analysis (MBMA) at GSK: Real-World Impact on Strategy and Trials

Certara Products, Certara Services, Drug Development, Model Informed Drug Development, Model-Based Meta-Analysis (MBMA), Modeling and Simulation, Therapeutic Specialties, Blog

Recapping a record-breaking 2025 Krakow HTA Symposium

event, Late clinical - blog, Modeling and Simulation, Blog

Optimizing Dosing and Regulatory Outcomes in Duchenne Muscular Dystrophy (DMD) Drug Development

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Case Study
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.